AXT Inc. has announced a regulatory issue following the passing of Christine Russell, a member of its Board of Directors, on July 11, 2025. Russell's death has reduced the company's Audit Committee to two independent directors, which falls short of the Nasdaq Listing Rule 5605(c)(2)$(A)$ requirement for a minimum of three independent directors. AXT Inc. has informed the Nasdaq Stock Market LLC of this non-compliance and has been given a cure period to address the issue by the earlier of its next annual stockholders' meeting or July 11, 2026. The company plans to restore compliance by appointing a new independent director before the expiration of the cure period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.